Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
Clinical trial NCT04596098 · COMPLETED
Trial details
- NCT number
- NCT04596098
- Sponsor
- University Hospital, Grenoble
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-30
- Primary completion
- 2022-05-16
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.